Key Takeaways

Lynkuet (elinzanetant) is a new nonhormonal drug that reduces moderate to severe hot flashes and night sweats by targeting two brain receptors involved in temperature control.

The drug is intended for people who can’t take or prefer to avoid hormone replacement therapy for menopause symptoms.

Common side effects include headache, fatigue, and dizziness, and users must complete liver function tests before and after starting treatment.

Lynkuet (elinzanetant), a new nonhormonal drug made by Bayer, is now available for treating moderate to severe hot flashes and night sweats caused by menopause.

Hot flashes and night sweats affect up to 80% of women during menopause and can last seven to 10 years. These symptoms can also lead to sleep problems and mood changes that affect

See Full Page